• Press Release

Icahn School of Medicine at Mount Sinai Unveils New Master’s Degree in Biomedical Data Science

  • New York, NY
  • (November 15, 2018)

The Graduate School of Biomedical Sciences at the Icahn School of Medicine at Mount Sinai is pleased to announce a new Master of Biomedical Data Science (MSBDS) degree. Applications are open now through June 2019 for enrollment in the fall of 2019. 

The MSBDS program aims to motivate students with a strong computational background to work on complex biomedical problems and diseases. “Data scientists are in demand right now across a wide range of industries. Those who have been trained in a health care environment and are used to working on biomedical problems will be especially well positioned to tackle future challenges in the health care industry,” said Eric Sobie, PhD, Co-Director of the MSBDS program. The program offers access to innovative coursework in various aspects of biomedical sciences, integrated with machine learning, computer sciences, big data analysis and visualization, and the use of large electronic medical record-linked biomedical repositories.  

The new MSBDS program is part of a larger effort, the Biomedical Data Science Initiative, created to bridge research and educational endeavors in computing and big data analytics across various departments and institutes within the Mount Sinai Health System.

“As we celebrate our 50-year anniversary, we are expanding and reimagining the advanced education and professional training we offer our students, providing them with the opportunity to develop the specialized skills that are necessary to succeed in twenty-first century biomedical and health care science,” said Marta Filizola, PhD, Dean of the Graduate School of Biomedical Sciences and Sharon and Frederick Klingenstein/Nathan Kase, M.D. Professor of Pharmacological Sciences at the Icahn School of Medicine.  “It’s not enough to train our students for academia. Therefore, we are constantly refining our paradigm for the student who is interested in industry, allied health care professions, consulting, finance, medical and scientific writing, government, and nonprofit work.”

In addition to the new master’s program, the Icahn School of Medicine has expanded its resources to grow data science opportunities at the PhD level as well. The Genetics and Data Science research area within the PhD program in Biomedical Sciences offers students the opportunity to collaborate with faculty on translational research through the integration of genomic technology and data analysis. This expansion comes on the heels of the school’s launch of its newly renamed Icahn Institute for Data Science and Genomic Technology, which plays a leading role in Mount Sinai’s systemwide dedication to precision medicine—an increasingly popular medical model that analyzes patients at the cellular and genetic levels to customize clinical care.


About the Mount Sinai Health System

The Mount Sinai Health System is New York City's largest integrated delivery system encompassing seven hospital campuses, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai's vision is to produce the safest care, the highest quality, the highest satisfaction, the best access and the best value of any health system in the nation. The System includes approximately 6,600 primary and specialty care physicians; 10 joint-venture ambulatory surgery centers; more than 140 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report's "Best Medical Schools", aligned with a U.S. News & World Report's "Honor Roll" Hospital, No. 13 in the nation for National Institutes of Health funding, and among the top 10 most innovative research institutions as ranked by the journal Nature in its Nature Innovation Index. This reflects a special level of excellence in education, clinical practice, and research. The Mount Sinai Hospital is ranked No. 18 on U.S. News & World Report's "Honor Roll" of top U.S. hospitals; it is one of the nation's top 20 hospitals in Cardiology/Heart Surgery, Gastroenterology/GI Surgery, Geriatrics, Nephrology, and Neurology/Neurosurgery, and in the top 50 in six other specialties in the 2018-2019 "Best Hospitals" issue. Mount Sinai's Kravis Children's Hospital also is ranked nationally in five out of ten pediatric specialties by U.S. News & World Report. The New York Eye and Ear Infirmary of Mount Sinai is ranked 11th nationally for Ophthalmology and 44th for Ear, Nose, and Throat, while Mount Sinai Beth Israel, Mount Sinai St. Luke's and Mount Sinai West are ranked regionally.

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.